The Cardiologs AI-enabled software being used to remotely monitor a cardiac patient.
November 20, 2021 – Philips announced it signed an agreement to acquire Cardiologs, a France-based medical technology company focused on cardiac diagnostics using artificial intelligence (AI) and cloud technology. Cardiologs will further strengthen Philips’ cardiac monitoring and diagnostics offering with innovative software technology, electrocardiogram (ECG) analysis and reporting services.
The transaction, which is subject to customary closing conditions, is expected to be completed in the coming months. Financial details of the transaction were not disclosed.
Philips said the acquisition of Cardiologs is a strong fit with its existing portfolio of cardiac care solutions. This includes real-time patient monitoring, therapeutic devices, telehealth and informatics for the hospital, as well as ambulatory cardiac diagnostics and monitoring solutions, that were added through the recent acquisition of BioTelemetry Inc.
Cardiologs will complement this offering with a vendor-neutral heart disorder screener and ECG analysis applications based on machine learning algorithms. Developed in partnership with leading physicians, Cardiologs’ technology accelerates diagnostic reporting, decreases the occurrence of reporting errors and streamlines clinician workflow and patient care, empowering clinicians to deliver expert cardiac care faster and more efficiently.
CE-marked and FDA cleared for detection of cardiac arrhythmias, Cardiologs’ technology is built on a growing database of more than 20 million ECG recordings and supported by a number of clinical publications.
“Offering superb clinical insights, as well as automated clinical reporting, Cardiologs’ medical-grade AI technology and data scientists will be a strong addition to our growing portfolio of cardiac solutions for hospital and ambulatory settings,” said Roy Jakobs, chief business leader connected care at Philips Healthcare. “Philips’ global footprint can accelerate the availability of Cardiologs’ technology to patients all over the world and further deliver on the quadruple aim of an improved patient care experience, better health outcomes, improved staff experience, and lower cost of care.”
“We are delighted to become part of Philips and continue innovating together to provide solutions that empower clinicians all around the world,” said Yann Fleureau, co-founder and CEO of Cardiologs. “We look forward to the opportunity to expand the business as part of Philips, maintaining vendor neutrality and continuing to work with third party vendors to drive further adoption of digital health solutions globally.”
Cardiologs Recently Launched a Remote Cardiac Monitoring Platform
The company launch the Cardiologs RPM this summer at the Heart Rhythm 2021 meeting. It unlocks the potential of smartwatches for remote cardiac patient monitoring. The platform is the company's first venture into the remote patient monitoring space, bringing its foundational ECG analysis tool to a more direct level of patient care with the goal of going beyond the world of arrhythmias.
Cardiologs is collaborating with cardiologists at three medical centers in France to strengthen their cardiology services. Over the past year, Pasteur Clinic (Toulouse), Ambroise Paré Clinic (Neuilly sur Seine) and Cardioréliance – Centre Cardiologique d'Orléans – Pôle Santé Oréliance center (Orléans) have all started using the company's deep-learning platform to support clinicians with automated electrocardiogram (ECG) analysis and diagnostics. The centers said since the start of COVID, the technology has helped reduce the time it takes to read and assess the growing number of ECGs being processed.
Cardiologs was founded in 2014 and is headquartered in Paris, France. It has about 70 employees, largely comprising software engineers and data scientists with expertise in AI and deep learning algorithms. They will join Philips and will expand the company’s continued AI-focused innovation activities together with the company’s R&D lab in Paris. Philips has a strong presence in France, consisting of research and development activities, as well as sales, marketing and distribution at multiple sites.
For more information: https://cardiologs.com/
April 12, 2024 
